中国老年保健医学
中國老年保健醫學
중국노년보건의학
CHINESE JOURNAL OF GERIATRIC CARE
2014年
6期
22-24,25
,共4页
EphB4mRNA%EphrinB2mRNA%子宫内膜癌%RT-PCR
EphB4mRNA%EphrinB2mRNA%子宮內膜癌%RT-PCR
EphB4mRNA%EphrinB2mRNA%자궁내막암%RT-PCR
EphB4mRNA%EphrinB2mRNA%endometrical carcinoma%RT-PCR
目的:研究EphB4mRNA和EphrinB2mRNA在子宫内膜癌中的表达及其意义。方法应用逆转录-聚合酶链式反应( RT-PCR)分别检测经免疫组化证实有不同级别的EphB4和EphrinB2蛋白表达的35例子宫内膜癌冰冻标本中的mRNA水平。比较各自与其蛋白表达的相关性及与临床病理因素的关系。结果子宫内膜癌组织中EphB4mRNA和EphrinB2 mRNA的表达均与组织学分级、淋巴结转移及临床分期均显著相关( P<0.05).EphB4和EphrinB2蛋白表达和mRNA表达水平不完全一致。结论 EphB4、EphrinB与子宫内膜癌的发生发展有关。其联合检测有助于客观评估子宫内膜癌的生物学行为,可用来指导临床用药和预测预后。
目的:研究EphB4mRNA和EphrinB2mRNA在子宮內膜癌中的錶達及其意義。方法應用逆轉錄-聚閤酶鏈式反應( RT-PCR)分彆檢測經免疫組化證實有不同級彆的EphB4和EphrinB2蛋白錶達的35例子宮內膜癌冰凍標本中的mRNA水平。比較各自與其蛋白錶達的相關性及與臨床病理因素的關繫。結果子宮內膜癌組織中EphB4mRNA和EphrinB2 mRNA的錶達均與組織學分級、淋巴結轉移及臨床分期均顯著相關( P<0.05).EphB4和EphrinB2蛋白錶達和mRNA錶達水平不完全一緻。結論 EphB4、EphrinB與子宮內膜癌的髮生髮展有關。其聯閤檢測有助于客觀評估子宮內膜癌的生物學行為,可用來指導臨床用藥和預測預後。
목적:연구EphB4mRNA화EphrinB2mRNA재자궁내막암중적표체급기의의。방법응용역전록-취합매련식반응( RT-PCR)분별검측경면역조화증실유불동급별적EphB4화EphrinB2단백표체적35례자궁내막암빙동표본중적mRNA수평。비교각자여기단백표체적상관성급여림상병리인소적관계。결과자궁내막암조직중EphB4mRNA화EphrinB2 mRNA적표체균여조직학분급、림파결전이급림상분기균현저상관( P<0.05).EphB4화EphrinB2단백표체화mRNA표체수평불완전일치。결론 EphB4、EphrinB여자궁내막암적발생발전유관。기연합검측유조우객관평고자궁내막암적생물학행위,가용래지도림상용약화예측예후。
Objective To study the expressions of EphB4mRNA,EphrinB2mRNA in endometrical carcinomas and to explore their significance.Methods The levels of EphB4 and EphrinB2 mRNA in frozen tissues of 35 endometrical carcinoma cases in which the tumours showed different grades were detected by RT-PCR and compared if the levels of mRNA correspond to their levels of protein and clinicopathological features.Results The positive expressions of EphB4mRNA and EphrinB2mRNA were both associ-ated with histological grade,lymph node metastasis and clinical stage respectively(P<0.05).The expression of EphB4mRNA and EphrinB2 did not fully correspond to their protein expression in endometrical carcinoma.Conclusions EphB4,EphrinB2 may be in-volved in carcinogenesis,development procedures of endometrical carcinoma.The combined detection of them can help to predict the clinical and pathologic characteristics of endometrial carcinoma and to guide treatment and tell the progonosis.